Using network pharmacology tools, Martiz and colleagues reported the virtual screening of isoeugenol as an inhibitor of glyceraldehyde 3‐phosphate dehydrogenase (GAPDH), a common target for both T2D and AD. This evidence concerns the gene GAPDH and Alzheimer disease.